Dr. Vandana B. Patravale is currently a Professor of Pharmaceutics at the Institute of Chemical Technology, Mumbai, India. She has around 30 years of teaching and research experience. She has over 200 refereed publications with over 9000 citations , 22 granted patents , 20 patents in pipeline and 2 trademark registries. She has published 2 books and 25 book chapters with international publishers. Dr. Patravale has been active in teaching, research and service throughout her career. She has recently been inducted as an independent director of a device manufacturing company and listed as top 2% of World scientist’s in pharmacy. Her areas of research include development of nanocarriers with major emphasis on infectious diseases, cancer and neurodegenerative disorders; medical device development, nanodiagnostics and nanovaccines. She was awarded Abdul Kalam Technology Innovation National Fellowship 2021,Fellowship of Indian Chemical Society 2020, Kukreja Oration award 2020,APTIs Dr. Manjushree Pal Best Pharmaceutical Scientist Award 2019, Shri Amrut Mody distinguished researcher award 2018, OPPI women scientist award 2015, Bill Melinda Gates grant award 2015,Best Pharmaceutical Scientist award 2014, VASVIK award 2013, Veneto nanotech award 2013, APTI best teacher award 2012, Fellowship of Maharashtra Academy of Sciences, 2011and K.H. Garda Distinguished researcher award 2009. She is Vice president-CRS Indian chapter, editorial board member DDTR, editor CRS IC and APTI women forum newsletters. She is actively collaborating with researchers as well as industries within country and abroad and has completed Indo-Swiss, Indo-Japan, Indo-UK projects. She is executing all major grants from Indian Government focusing on product development. She has transferred about 20 technologies to industry including drug eluting stents being marketed in more than 65 countries.